SPOP-mutant cancers generally lack genetic alterations in the PIK3 pathway [14, 20] but show a distinct pattern of genomic alterations, including losses of CHD1 at 5q21, 2q, and 6q [14, 79]. The gene discussed is SPOP; the disease is cancer.